Literature DB >> 9811061

Identification of elements in the promoter region of the alpha1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis.

E G Hitraya1, J Varga, C M Artlett, S A Jiménez.   

Abstract

OBJECTIVE: To identify regulatory elements in the promoter region of the alpha1(I) procollagen gene (COL1A1) involved in the transcriptional activation of this gene in systemic sclerosis (SSc), and to identify the transcription factors interacting with these regulatory elements.
METHODS: Dermal fibroblasts from 6 patients with diffuse SSc of recent onset and from 6 healthy individuals were studied. The transcriptional regulation of COL1A1 was examined by transient transfections with deletion constructs containing portions of the COL1A1 promoter. The DNA binding activity of nuclear proteins recognizing the regulatory regions in the COL1A1 promoter was examined by gel mobility shift assays. A procedure was established to allow the quantitative determination of the amount of DNA binding proteins interacting with the COL1A1 promoter, employing DNA binding protein and DNA titration experiments analyzed by gel mobility shift assays.
RESULTS: Maximal chloramphenicol acetyltransferase activity was observed with a -174-bp to +42-bp COL1A1 promoter construct in both normal and SSc cells; however, the activity driven by this construct was 70-260% higher in SSc fibroblasts. Most of the transcriptional activity of the COL1A1 promoter was contained in a minimal promoter region encompassing -174 bp to -84 bp. Electrophoretic mobility shift assays performed with oligonucleotides corresponding to the regions spanning -129/-107 bp and -104/-78 bp of the COL1A1 promoter revealed marked increases in the intensities of DNA-protein complexes formed with both oligonucleotides in nuclear extracts prepared from each of the SSc cell lines in comparison with normal fibroblasts. Competition experiments showed that each of these regions contained elements recognized by Sp1 and nuclear factor 1 (NF-1) binding proteins. A quantitative determination of DNA binding activity recognizing the Sp1 binding element within the -129/-107-bp region showed that it was 23.6 nM in SSc fibroblasts compared with 6.9 nM in normal fibroblasts.
CONCLUSION: The results demonstrate that a short region in the proximal promoter of COL1A1 containing 2 tandem NF-1/Sp1 elements displays up-regulated transcriptional activity in SSc fibroblasts, and that SSc fibroblasts contain 3.4-fold greater DNA binding activity recognizing these elements than normal cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811061     DOI: 10.1002/1529-0131(199811)41:11<2048::AID-ART21>3.0.CO;2-X

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

Review 1.  The genetics of systemic sclerosis.

Authors:  Randall W Johnson; Monty B Tew; Frank C Arnett
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

2.  The p65 subunit of NF-κB inhibits COL1A1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3).

Authors:  Gallic Beauchef; Nicolas Bigot; Magdalini Kypriotou; Emmanuelle Renard; Benoît Porée; Russell Widom; Anne Dompmartin-Blanchere; Thierry Oddos; François-Xavier Maquart; Magali Demoor; Karim Boumediene; Philippe Galera
Journal:  J Biol Chem       Date:  2011-12-02       Impact factor: 5.157

3.  Inhibition of collagen gene expression in systemic sclerosis dermal fibroblasts by mithramycin.

Authors:  N Sandorfi; N Louneva; E Hitraya; G Hajnoczky; B Saitta; S A Jimenez
Journal:  Ann Rheum Dis       Date:  2005-05-18       Impact factor: 19.103

4.  Sp1king out cancer (....and fibrosis?).

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2011-08-06       Impact factor: 5.782

5.  Mithramycin reduces expression of fibro-proliferative mRNAs in human gingival fibroblasts.

Authors:  O A Fajardo; K Thompson; S K Parapuram; S Liu; A Leask
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

Review 6.  Alterations in the regulation of expression of the alpha 1(I) collagen gene (COL1A1) in systemic sclerosis (scleroderma).

Authors:  S A Jimenez; B Saitta
Journal:  Springer Semin Immunopathol       Date:  1999

Review 7.  Novel therapeutic strategies in scleroderma.

Authors:  C P Denton; C M Black
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

8.  Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.

Authors:  Masahide Kubo; Joanna Czuwara-Ladykowska; Omar Moussa; Margaret Markiewicz; Edwin Smith; Richard M Silver; Stefania Jablonska; Maria Blaszczyk; Dennis K Watson; Maria Trojanowska
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

9.  B-Myb acts as a repressor of human COL1A1 collagen gene expression by interacting with Sp1 and CBF factors in scleroderma fibroblasts.

Authors:  Lucia Cicchillitti; Sergio A Jimenez; Arturo Sala; Biagio Saitta
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

10.  Sp1 Mediates a Therapeutic Role of MiR-7a/b in Angiotensin II-Induced Cardiac Fibrosis via Mechanism Involving the TGF-β and MAPKs Pathways in Cardiac Fibroblasts.

Authors:  Rui Li; Jie Xiao; Xiaoteng Qing; Junhui Xing; Yanfei Xia; Jia Qi; Xiaojun Liu; Sen Zhang; Xi Sheng; Xinyu Zhang; Xiaoping Ji
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.